BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15850906)

  • 1. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy.
    Liu Q; Cai XW; Wu B; Zhu ZF; Chen HQ; Fu XL
    PLoS One; 2014; 9(5):e97225. PubMed ID: 24820177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
    Du R; Fan S; Yang D; Wang X; Hou X; Zeng C; Guo D; Tian R; Jiang L; Dong X; Yu R; Yu H; Zhu S; Li J; Shi A
    BMC Cancer; 2024 May; 24(1):596. PubMed ID: 38755542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
    Deng W; Yang J; Ni W; Li C; Chang X; Han W; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Deng L; Wang W; Bi N; Zhang T; Li Y; Gao S; Xue Q; Mao Y; Sun K; Liu X; Fang D; Wang D; Li J; Zhao J; Shao K; Li Z; Chen X; Han L; Wang L; He J; Xiao Z
    Oncologist; 2020 Apr; 25(4):e701-e708. PubMed ID: 32083766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.
    Hashiguchi T; Nasu M; Hashimoto T; Kuniyasu T; Inoue H; Sakai N; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Tsurumaru M; Kajiyama Y
    Mol Clin Oncol; 2014 Sep; 2(5):719-724. PubMed ID: 25054036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study on the Efficacy of Precise Radiotherapy in Lymphatic Drainage Area of Esophageal Cancer between Preventive Radiation and Invasive Field Radiation.
    Huang W; Shi H; Ma R
    Altern Ther Health Med; 2024 Mar; 30(3):76-79. PubMed ID: 37883770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does increasing the number of resected lymph nodes really improve the prognosis of patients with esophageal squamous cell carcinoma?
    Liu BW; Gu YM; Chen LQ
    Int J Surg; 2024 Jan; 110(1):602-603. PubMed ID: 37800554
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.
    Zieren HU; Müller JM; Jacobi CA; Pichlmaier H; Müller RP; Staar S
    World J Surg; 1995; 19(3):444-9. PubMed ID: 7639004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Metastatic Lymph Nodes Using Indocyanine Green Fluorescence Imaging.
    Kim K; Han KN; Choi BH; Rho J; Lee JH; Eo JS; Kim C; Kim BM; Jeon OH; Kim HK
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9).
    Ai D; Chen Y; Liu Q; Deng J; Zhang X; Zhang J; Chu L; Shen J; Ma L; Zhang Y; Chen H; Miao L; Zhao K; Xiang J
    Radiat Oncol; 2023 Feb; 18(1):26. PubMed ID: 36750858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of salvage radiotherapy in patients with supraclavicular lymph node metastases after esophagectomy.
    Ping Z; Chanjun Z; Wenwen B; Mingyue C; Quanbing S; Yajing W; Zhiguo Z
    Front Oncol; 2022; 12():1016150. PubMed ID: 36713563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer.
    Zhang Y; Zhang Y; Peng L; Zhang L
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variant of
    Xu X; Sun Z; Rong L; Wang X; Xu L; Lu J; Ye Q; Zhang L; Bai Y; Ma X
    Front Genet; 2022; 13():988433. PubMed ID: 36212135
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node-positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
    Fang S; Zhong J; Mai Z; Li T; Xie X; Fu J
    Cancer Med; 2023 Feb; 12(4):4077-4086. PubMed ID: 36134648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501).
    Mao YS; Gao SG; Li Y; Hao AL; Liu JF; Li XF; Rong TH; Fu JH; Ma JQ; Xu MQ; Zhang RQ; Xiao GM; Fu XN; Chen KN; Mao WM; Liu YY; Liu HX; Zhang ZR; Fang Y; Fu DH; Wei XD; Yuan LG; Muhammad S; Wei WQ; Chiu PW; Lloyd S; Schlottmann F; Meredith K; Pimiento JM; Gao YB; He J
    Ann Transl Med; 2022 Aug; 10(16):904. PubMed ID: 36111056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial.
    Li H; Gu D; Du M; Zhou G; Zhang Z; Ye J
    Front Oncol; 2022; 12():900443. PubMed ID: 35847922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation.
    Cellini F; Manfrida S; Casà C; Romano A; Arcelli A; Zamagni A; De Luca V; Colloca GF; D'Aviero A; Fuccio L; Lancellotta V; Tagliaferri L; Boldrini L; Mattiucci GC; Gambacorta MA; Morganti AG; Valentini V
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
    Chang X; Chen J; Zhang W; Yang J; Yu S; Deng W; Ni W; Zhou Z; Chen D; Feng Q; Lv J; Liang J; Hui Z; Wang L; Lin Y; Chen X; Xue Q; Mao Y; Gao Y; Wang D; Feng F; Gao S; He J; Xiao Z
    Ther Adv Med Oncol; 2021; 13():17588359211061948. PubMed ID: 34987617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of postoperative radiotherapy with small T-shaped field in thoracic esophageal squamous cell carcinoma.
    Zhao Q; Zhu J; Liu Y; Qin S; Zhou J
    J Gastrointest Oncol; 2021 Oct; 12(5):2004-2012. PubMed ID: 34790368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
    Ni W; Yu S; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D; Zhao J; Gao Y
    Oncologist; 2021 Dec; 26(12):e2151-e2160. PubMed ID: 34309117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.